Skip to main content
. 2015 Jun 2;135(1):42–50. doi: 10.3109/00016489.2014.952047

Table III.

Response (healed or improved) to treatment from visit 2 (day 3) to visit 5 (day 14): FAS and PP.

  FAS
PP
Response to treatment BNO 1016 480 mg (n = 294) Placebo (n = 295) BNO 1016 480 mg (n = 213) Placebo (n = 220)
Visit 2 (day 3) 57.8% 55.6% 60.6% 55.9%
p value* = 0.5455 p value* = 0.3243
Visit 3 (day 7) 86.1% 78.0% 89.7% 76.4
p value* = 0.0076 p value* = 0.0002
Visit 4 (day 10) 90.8% 80.7% 95.8% 80.5%
p value* = 0.0002 p value* < 0.0001
Visit 5 (day 14) 93.2% 85.1% 94.8% 83.6%
p value* = 0.0016 p value* = 0.0002

*Two-sided; alpha = 0.05.

Cochran–Mantel–Haenszel test.

FAS, full analysis set; PP, per-protocol population.